The aim of this study was to evaluate the effects of simultaneous use of Epo and LFM-A13 on the viability of breast cancer cells, both MCF-7 and MDA-MB-231 lines, in vitro and in zebrafish embryo xenograft model. Here, EPO is linked to breast cancer.